Hayashi Katsuhide, Paul Aritra, Chung Roy, Nakhla Shady, Tabaja Chadi, Martin David O, Callahan Thomas, Baranowki Bryan, Kanj Mohamed, Taigen Tyler, Varma Niraj, Wazni Oussama, Rickard John
Cardiac Electrophysiology and Pacing Section, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
Department of Heart Rhythm Management, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.
J Cardiovasc Electrophysiol. 2025 Aug;36(8):1987-1995. doi: 10.1111/jce.16767. Epub 2025 Jul 9.
The incidence and predictors of pacing-induced cardiomyopathy (PICM) in patients undergoing attempted left bundle branch area pacing (LBBAP) are unknown.
To examine the incidence and predictors of PICM in patients with preserved left ventricular ejection fraction (LVEF) and atrioventricular block (AVB) undergoing attempted LBBAP.
The study cohort included consecutive patients undergoing an attempt at LBBAP at the Cleveland Clinic from 2018 until 2022 with preserved LVEF and AVB. PICM was defined as post-PM LVEF decrease to < 50% and > 5%, > 10% decrease from pre-PM implantation. Patients who had alternative reasons for a decrease in LVEF during follow-up were excluded. LBBAP was defined as meeting common criteria for LBBAP and the incidence of PICM was evaluated.
A total of 173 patients were included. PICM developed in 13/173 (7.5%) of patients at 26 (IQR 7-70) weeks after PM implantation. In total, 12 (6.9%) patients experienced LVEF > 10% decrease. Of 173 patients, 118 (68.2%) patients met criteria for LBBAP. The LBBAP group had a significantly lower incidence of PICM compared with the non-LBBAP group (log rank p = 0.048). The optimal V6RWPT for predicting PICM was 80 ms and the incidence of PICM increased in proportion to the increase in V6RWPT. In multivariate analysis, non-LBBA capture (HR: 5.58, 95% CI: 1.46-24.32; p = 0.01) and LVEF at pre-PM implant per 10% (HR: 0.11, 95% CI: 0.02-0.40; p = 0.0003) were independent predictors for the development of PICM.
The incidence of PICM with LBBAP in paced patients undergoing PM implant with AVB and preserved LVEF is low. LBBA capture was associated with freedom from PICM.
尝试进行左束支区域起搏(LBBAP)的患者中,起搏诱导性心肌病(PICM)的发生率及预测因素尚不清楚。
研究左心室射血分数(LVEF)保留且患有房室传导阻滞(AVB)的患者在尝试进行LBBAP时PICM的发生率及预测因素。
研究队列包括2018年至2022年在克利夫兰诊所连续接受LBBAP尝试且LVEF保留和患有AVB的患者。PICM定义为起搏器植入后LVEF下降至<50%且较植入前下降>5%、>10%。排除随访期间LVEF下降有其他原因的患者。LBBAP定义为符合LBBAP的常见标准,并评估PICM的发生率。
共纳入173例患者。13/173(7.5%)的患者在起搏器植入后26(四分位间距7 - 70)周发生PICM。总计12(6.9%)例患者LVEF下降>10%。173例患者中,118(68.2%)例符合LBBAP标准。与非LBBAP组相比,LBBAP组PICM的发生率显著更低(对数秩检验p = 0.048)。预测PICM的最佳V6RWPT为80毫秒,且PICM的发生率随V6RWPT的增加而呈比例增加。多因素分析中,非左束支区域夺获(HR:5.58,95%CI:1.46 - 24.32;p = 0.01)和起搏器植入前每10%的LVEF(HR:0.11,95%CI:0.02 - 0.40;p = 0.0003)是PICM发生的独立预测因素。
在接受起搏器植入且患有AVB和LVEF保留的起搏患者中,LBBAP时PICM的发生率较低。左束支区域夺获与无PICM相关。